EGFR and non-small cell lung carcinoma: Therefore, in consistent with in vitro signaling findings, ASP4132 administration induced AMPK activation, mTORC1 inhibition, RTKs (EGFR and PDGFRα) degradation and downstream Akt inactivation, as well as autophagy induction in NSCLC xenograft tissues.